These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6594240)

  • 21. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. IV. N-formimidoyl thienamycin.
    Traub WH
    Chemotherapy; 1983; 29(2):121-7. PubMed ID: 6340990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
    Sader HS; Jones RN
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sensitivity to blood bactericidal activity and hydrophobicity of Acinetobacter baumannii after treatment with imipenem].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1999 Apr; 48(2):67-70. PubMed ID: 10349782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
    Quentin C; Noury P; Laurent C; Saivin S; Bebear C
    Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
    Kern W; Gulden H; Vanek E; Kurrle E
    Chemotherapy; 1988; 34(2):117-26. PubMed ID: 3164670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates.
    Murray PR; Niles AC
    Diagn Microbiol Infect Dis; 1990; 13(1):57-61. PubMed ID: 2331851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital.
    Santos-Ferreira MO; Vital JO
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():23-6. PubMed ID: 3469195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of biapenem, a new carbapenem antibiotic.
    Clarke AM; Zemcov SJ
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):377-84. PubMed ID: 8354306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-lactams and imipenem.
    Kirkpatrick B; Ashby J; Wise R
    Lancet; 1986 Apr; 1(8484):802. PubMed ID: 2870295
    [No Abstract]   [Full Text] [Related]  

  • 30. In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem.
    Van der Auwera P; Ernst F; Grenier P; Glupczynski Y; Husson M; Klastersky J
    J Antimicrob Chemother; 1987 Aug; 20(2):179-89. PubMed ID: 3478328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
    Bastianini L; Sposini T; Bartoli A; Marconi P
    Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms.
    Baquero F; Culebras E; Patrón C; Pérez-Díaz JC; Medrano JC; Vicente MF
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():47-59. PubMed ID: 3546247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter in vitro evaluation of SM-7338, a new carbapenem.
    Jones RN; Aldridge KE; Allen SD; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA
    Antimicrob Agents Chemother; 1989 Apr; 33(4):562-5. PubMed ID: 2658796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of imipenem against gram-positive anaerobic bacteria.
    Dubreuil L; Devos J; Romond C
    Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Mycobacterium fallax to imipenem and twenty other antimicrobial agents.
    Haas H; Zubi R; Sacks TG
    Eur J Clin Microbiol; 1984 Oct; 3(5):489-91. PubMed ID: 6594239
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
    Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria.
    Malanoski GJ; Collins L; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2009-16. PubMed ID: 8239623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
    Aznar J; García Iglesias MC; Perea EJ
    J Antimicrob Chemother; 1984 Feb; 13(2):129-32. PubMed ID: 6423613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem.
    Bannatyne RM; Cheung R
    Antimicrob Agents Chemother; 1984 Oct; 26(4):604-5. PubMed ID: 6097171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.